Literature DB >> 24136390

Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.

Shuntaro Oka1, Hiroyuki Okudaira, Masahiro Ono, David M Schuster, Mark M Goodman, Keiichi Kawai, Yoshifumi Shirakami.   

Abstract

PURPOSE: We aimed to elucidate trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid (anti-[(18)F]FACBC) uptake mechanisms in inflammatory and tumor cells, in comparison with those of L-[methyl-(11)C]methionine ([(11)C]Met) and 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG). PROCEDURES: Using carbon-14-labeled tracers, in vitro time-course, pH dependence, and competitive inhibition uptake experiments were performed in rat inflammatory (T cells, B cells, granulocytes, macrophages), prostate cancer (MLLB2), and glioma (C6) cells.
RESULTS: Anti-[(14)C]FACBC uptake ratios of T/B cells to tumor cells were comparable, while those of granulocytes/macrophages to tumor cells were lower than those for [(14)C]FDG. Over half of anti-[(14)C]FACBC uptake by T/B and tumor cells was mediated by Na(+)-dependent amino acid transporters (system ASC), whereas most [(14)C]Met transport in all cells was mediated by Na(+)-independent carriers (system L).
CONCLUSIONS: The low anti-[(18)F]FACBC accumulation in granulocytes/macrophages may be advantageous in discriminating inflamed regions from tumors. The significant anti-[(18)F]FACBC uptake in T/B cells may cause false-positives in some cancer patients who undergo FACBC-positron emission tomography (PET).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24136390     DOI: 10.1007/s11307-013-0693-0

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  33 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Neutrophil infiltration into human gliomas.

Authors:  G Fossati; G Ricevuti; S W Edwards; C Walker; A Dalton; M L Rossi
Journal:  Acta Neuropathol       Date:  1999-10       Impact factor: 17.088

3.  Low membrane transport activity for cystine in resting and mitogenically stimulated human lymphocyte preparations and human T cell clones.

Authors:  H Gmünder; H P Eck; W Dröge
Journal:  Eur J Biochem       Date:  1991-10-01

4.  Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.

Authors:  Hideo Tsukada; Kengo Sato; Dai Fukumoto; Shingo Nishiyama; Norihiro Harada; Takeharu Kakiuchi
Journal:  J Nucl Med       Date:  2006-04       Impact factor: 10.057

Review 5.  Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection?

Authors:  P Newsholme
Journal:  J Nutr       Date:  2001-09       Impact factor: 4.798

6.  Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors.

Authors:  Wenchao Qu; Shunichi Oya; Brian P Lieberman; Karl Ploessl; Limin Wang; David R Wise; Chaitanya R Divgi; Lewis A Chodosh; Lewis P Chodosh; Craig B Thompson; Hank F Kung
Journal:  J Nucl Med       Date:  2011-12-15       Impact factor: 10.057

7.  Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine.

Authors:  T Ishii; Y Sugita; S Bannai
Journal:  J Cell Physiol       Date:  1987-11       Impact factor: 6.384

8.  Amino acid transport systems beta and A in fetal T lymphocytes in intrauterine growth restriction and with tumor necrosis factor-alpha treatment.

Authors:  Chibuike G Iruloh; Stephen W D'Souza; William D Fergusson; Philip N Baker; Colin P Sibley; Jocelyn D Glazier
Journal:  Pediatr Res       Date:  2009-01       Impact factor: 3.756

9.  Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT.

Authors:  Songji Zhao; Yuji Kuge; Masashi Kohanawa; Toshiyuki Takahashi; Yan Zhao; Min Yi; Kakuko Kanegae; Koh-Ichi Seki; Nagara Tamaki
Journal:  J Nucl Med       Date:  2007-12-12       Impact factor: 10.057

Review 10.  The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction.

Authors:  Matthias A Hediger; Michael F Romero; Ji-Bin Peng; Andreas Rolfs; Hitomi Takanaga; Elspeth A Bruford
Journal:  Pflugers Arch       Date:  2003-11-18       Impact factor: 3.657

View more
  25 in total

1.  Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors.

Authors:  Ahlem Bouhlel; Dong Zhou; Aixiao Li; Liya Yuan; Keith M Rich; Jonathan McConathy
Journal:  J Med Chem       Date:  2015-05-04       Impact factor: 7.446

2.  Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.

Authors:  David M Schuster; Cristina Nanni; Stefano Fanti; Shuntaro Oka; Hiroyuki Okudaira; Yusuke Inoue; Jens Sörensen; Rikard Owenius; Peter Choyke; Baris Turkbey; Trond V Bogsrud; Tore Bach-Gansmo; Raghuveer K Halkar; Jonathon A Nye; Oluwaseun A Odewole; Bital Savir-Baruch; Mark M Goodman
Journal:  J Nucl Med       Date:  2014-11-13       Impact factor: 10.057

Review 3.  Role of molecular imaging in the detection of localized prostate cancer.

Authors:  Samuel J Galgano; Janelle T West; Soroush Rais-Bahrami
Journal:  Ther Adv Urol       Date:  2022-06-21

4.  Selective modification of fluciclovine (18F) transport in prostate carcinoma xenografts.

Authors:  F I Tade; W G Wiles; G Lu; B Bilir; O Akin-Akintayo; J S Lee; D Patil; W Yu; C Ormenisan Gherasim; B Fei; C S Moreno; A O Osunkoya; E J Teoh; S Oka; H Okudaira; M M Goodman; D M Schuster
Journal:  Amino Acids       Date:  2018-06-15       Impact factor: 3.520

Review 5.  Amino Acid Metabolism as a Target for Breast Cancer Imaging.

Authors:  Gary A Ulaner; David M Schuster
Journal:  PET Clin       Date:  2018-07

6.  Patient Demographics and Referral Patterns for [F-18]Fluciclovine-PET Imaging at a Tertiary Academic Medical Center.

Authors:  Samuel J Galgano; Carli E Calderone; Andrew M McDonald; Jeffrey W Nix; Mollie deShazo; Eddy S Yang; Jonathan E McConathy; Soroush Rais-Bahrami
Journal:  J Am Coll Radiol       Date:  2018-11-14       Impact factor: 5.532

Review 7.  Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies.

Authors:  Benjamin M Ellingson; Patrick Y Wen; Timothy F Cloughesy
Journal:  Cancer J       Date:  2021 Sep-Oct 01       Impact factor: 3.360

8.  Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for 18F-fluciclovine-PET/CT in delineating sites of recurrence and identifying patients with oligometastatic disease.

Authors:  Eric H Kim; Barry A Siegel; Eugene J Teoh; Gerald L Andriole
Journal:  Urol Oncol       Date:  2020-11-05       Impact factor: 2.954

Review 9.  6-[18F]fluoro-L-DOPA: a well-established neurotracer with expanding application spectrum and strongly improved radiosyntheses.

Authors:  M Pretze; C Wängler; B Wängler
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

10.  Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren's syndrome.

Authors:  Pilar Jimenez-Royo; Michele Bombardieri; Coziana Ciurtin; Michalis Kostapanos; Anwar R Tappuni; Natasha Jordan; Azeem Saleem; Teresa Fuller; Kathleen Port; Elena Pontarini; Davide Lucchesi; Robert Janiczek; Paul Galette; Graham Searle; Neel Patel; Lucy Kershaw; Calum Gray; Nirav Ratia; André van Maurik; Marius de Groot; Nicolas Wisniacki; Mats Bergstrom; Ruth Tarzi
Journal:  Rheumatology (Oxford)       Date:  2021-05-14       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.